BioAmber Inc.
BIOA
BIOA was delisted on the 8th of February, 2018.
4 hedge funds and large institutions have $756K invested in BioAmber Inc. in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 23 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
83% less capital invested
Capital invested by funds: $4.35M → $756K (-$3.59M)
85% less funds holding
Funds holding: 26 → 4 (-22)
96% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.04M |
| 2 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
+$45.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RS
Robeco Schweiz
Zurich,
Switzerland
|
-$599K |
| 2 |
VF
Virtu Financial
New York
|
-$92K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$60K |
| 4 |
BlackRock
New York
|
-$52K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$44K |
BIOA Hedge Fund Activity: Q1 2018 in Review
4 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q1 2018, worth a combined $756K — down 83% from $4.35M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of BIOA and 1 opened new positions — a net loss of 22 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $3.04M. The largest seller was Robeco Schweiz, exiting entirely with an estimated $599K sold.
- 4 institutional investors held BioAmber Inc. (BIOA) as of Q1 2018, down from 26 in Q4 2017.
- Funds reported $756K of BioAmber Inc. stock for Q1 2018, down 83% quarter-over-quarter.
- 1 fund opened new BioAmber Inc. positions in Q1 2018 and 23 closed out, a net change of -22 holders.
- The largest BioAmber Inc. buyer in Q1 2018 was Sabby Management, an estimated $3.04M added.
- The largest BioAmber Inc. seller in Q1 2018 was Robeco Schweiz, an estimated $599K sold.
Based on aggregated 13F filings for Q1 2018.